PASSAGE BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PASSAGE BIO, INC. (PASG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 186.17 thousand shares for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-09-03
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 181.80K shares.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 4.38K shares, a 99.58% decline year-over-year.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 10.59K shares, a 98.03% decline year-over-year.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 16.87K shares, a 98.05% decline year-over-year.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 2.57M shares, a 18.56% decline from fiscal 2023.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 3.16M shares, a 29.66% decline from fiscal 2022.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 4.49M shares, a 233.70% increase from fiscal 2021.
- PASSAGE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.35M shares, a 487.31% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 181.80K shares derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | 186.17K shares S-4/A · filed 2026-09-03 | 196.76K shares derived: sum of 3 quarters · filed 2026-09-03 | 213.63K shares derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-03-31 | 4.38K shares S-4 · filed 2026-07-21 | 14.96K shares derived: sum of 2 quarters · filed 2026-09-03 | 31.83K shares derived: sum of 3 quarters · filed 2026-09-03 | -915.13K shares derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | 10.59K shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | 27.45K shares derived: sum of 2 quarters · filed 2026-09-03 | -919.50K shares derived: sum of 3 quarters · filed 2026-09-03 | 125.53K shares S-4/A · filed 2026-09-03 |
| 2025-09-30 | 16.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -930.09K shares derived: sum of 2 quarters · filed 2025-11-10 | 114.94K shares 10-Q · filed 2025-11-10 | 651.35K shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | -946.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 98.07K shares 10-Q · filed 2025-08-12 | 634.49K shares derived: sum of 3 quarters · filed 2025-08-12 | 1.50M shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 1.05M shares 10-Q · filed 2025-05-13 | 1.58M shares derived: sum of 2 quarters · filed 2025-05-13 | 2.45M shares derived: sum of 3 quarters · filed 2025-05-13 | 3.08M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 536.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 1.40M shares derived: sum of 2 quarters · filed 2025-03-04 | 2.03M shares derived: sum of 3 quarters · filed 2025-03-04 | 2.57M shares 10-K · filed 2025-03-04 |
| 2024-09-30 | 865.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 1.50M shares derived: sum of 2 quarters · filed 2024-11-13 | 2.04M shares 10-Q · filed 2024-11-13 | 2.94M shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 632.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.17M shares 10-Q · filed 2024-08-08 | 2.07M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.27M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 537.28K shares 10-Q · filed 2024-05-14 | 1.44M shares derived: sum of 2 quarters · filed 2024-05-14 | 2.64M shares derived: sum of 3 quarters · filed 2024-05-14 | 2.94M shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 901.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 2.10M shares derived: sum of 2 quarters · filed 2024-03-04 | 2.41M shares derived: sum of 3 quarters · filed 2024-03-04 | 3.16M shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 1.20M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 1.50M shares derived: sum of 2 quarters · filed 2023-11-13 | 2.26M shares 10-Q · filed 2023-11-13 | 3.49M shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 305.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 1.06M shares 10-Q · filed 2023-08-07 | 2.29M shares derived: sum of 3 quarters · filed 2023-08-07 | 2.72M shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 752.73K shares 10-Q · filed 2023-05-11 | 1.98M shares derived: sum of 2 quarters · filed 2023-05-11 | 2.41M shares derived: sum of 3 quarters · filed 2023-05-11 | 3.64M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 1.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 1.66M shares derived: sum of 2 quarters · filed 2023-03-06 | 2.88M shares derived: sum of 3 quarters · filed 2023-03-06 | 4.49M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 431.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.65M shares derived: sum of 2 quarters · filed 2022-11-10 | 3.26M shares 10-Q · filed 2022-11-10 | 3.74M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 1.22M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 2.83M shares 10-Q · filed 2022-08-04 | 3.31M shares derived: sum of 3 quarters · filed 2022-08-04 | 3.49M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 1.61M shares 10-Q · filed 2022-05-16 | 2.09M shares derived: sum of 2 quarters · filed 2022-05-16 | 2.27M shares derived: sum of 3 quarters · filed 2022-05-16 | 2.85M shares derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | 479.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 665.31K shares derived: sum of 2 quarters · filed 2022-03-03 | 1.24M shares derived: sum of 3 quarters · filed 2022-03-03 | 1.35M shares 10-K · filed 2022-03-03 |
| 2021-09-30 | 185.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 760.27K shares derived: sum of 2 quarters · filed 2021-11-04 | 865.39K shares 10-Q · filed 2021-11-04 | 865.39K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 574.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 679.91K shares 10-Q · filed 2021-08-05 | 679.91K shares derived: sum of 3 quarters · filed 2021-08-05 | 774.62K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 105.13K shares 10-Q · filed 2021-05-05 | 105.13K shares derived: sum of 2 quarters · filed 2021-05-05 | 199.84K shares derived: sum of 3 quarters · filed 2021-05-05 | 199.84K shares derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | 94.72K shares derived: sum of 2 quarters · filed 2021-03-03 | 94.72K shares derived: sum of 3 quarters · filed 2021-03-03 | 229.05K shares 10-K · filed 2021-03-03 |
| 2020-09-30 | 94.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 94.72K shares derived: sum of 2 quarters · filed 2020-11-10 | 229.05K shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 134.33K shares 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | 134.33K shares 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 110.22K shares 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |